Scientists develop new version of medication to relieve severe forms of pain

Scientists have developed a new version of a medication, first isolated from the saliva of sea snails, that could be taken in pill form to relieve the most severe forms of pain as effectively as morphine but without risking addiction. An article on the topic appears in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

C&EN Senior Editor Bethany Halford notes that a sea snails' saliva contains chemicals that help the slow-moving creatures catch prey. They include chemicals that the snails inject into passing prey with hypodermic-needle-like teeth that shoot from their mouths like harpoons. Scientists already have transformed one of these chemicals into a pain-reliever for humans, but it has to be injected directly into the spinal cord, limiting its use.

Now scientists in Australia have developed a form of the painkiller that can be given by mouth. It relieves severe pain, such as that in people with peripheral neuropathy, at a much lower dose than existing medications and without the risk of causing addiction. The article quotes one expert as speculating that such a drug could revolutionize the treatment of the most severe forms of pain.

Source: American Chemical Society

Comments

  1. Tom Hennessy Tom Hennessy Canada says:

    They seem to have been 'beaten to the punch' By cobra toxin.
    Cobroxin - Cobroxin over-the-counter, clinically proven pain relief products treat moderate to severe pain more efficiency than morphine.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Small Solutions for Big Problems in Drug Discovery and Delivery